2nd Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$235,969
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Comments on Draft Guidance for Industry on Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unaproved new Uses of Approved Drugs and Approved or Cleared Medical Devices. Comments on Draft Prescription Drug User Fee Act IV Drug Safety Five-Year Plan; Communications to FDA staff regarding request for feedback on FDA's unapproved drug initiative. Communication with FDA staff regarding behind-the-counter availability of certain drugs. Comments on Patient Safety and Quality Improvement-Notice of Proposed Rulemaking. Nominations to National Advisory Council for Healthcare Research and Quality. Comments on designation of Medically Underserved Populations and Health Professional Shortage Areas Notice of Proposed Rulemaking.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2642 (110th)

Medicare/Medicaid MMM

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I, Section 182, Provision that revises definition of medically accepted indication for drugs and conflic of interest. Comments on proposed changes to the Hospital Inpatient Prospective Payment Systems and FY 2009 Rates-Proposed Rule.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6331 (110th)

Pharmacy PHA

S. 901, Health Centers Renewal Act of 2007 and S.2708, Caring for an Aging America Act of 2008. Include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2932, Poison Center Support, Enhancement, and Awareness Act of 2008 support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. Comments relating to standards and technologies for numerical identifier, validation, track and trace, and authentication for prescription drugs. Comments on Direct-to-Consumer Advertising. Comments on proposed National Institute for Occupational Safety and Health survey of healthcare workers' safety and health. Meetings with HRSA officials on general and common issues on pharmacy technicians, telepharmacy, loan forgiveness.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 901 (110th), S. 2708 (110th), S. 2932 (110th), H.R. 5491 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.